Dermata Therapeutics, Inc. Common Stock
DRMADermata Therapeutics, Inc. (DRMA) is a dermatology-focused biotech company dedicated to developing innovative treatments for skin conditions. The company leverages its expertise in dermatological sciences to create targeted therapies aimed at improving patient outcomes in various skin disorders.
Company News
U.S. stock futures traded mixed on Tuesday as the Santa Claus rally resumed after Monday's declines. Major indices showed minimal movement with the S&P 500 and Nasdaq 100 slightly lower in premarket trading. Key movers included Fonar Corp surging 24.49% on a take-private deal announcement, TEN Holdings jumping 16.31% on a private placement, Boein...
Dermata Therapeutics (NASDAQ: DRMA) stock surged 20.10% on Wednesday following the announcement of a $12.4 million private placement offering. The company will issue 2,022,062 common shares and warrants priced at $2.04 per share, with expected gross proceeds of $4.1 million. If warrants are fully exercised, the company could raise an additional $...
Enphase Energy reported mixed Q2 results, leading to a rise in its stock price. Several other companies saw significant pre-market movements, both positive and negative, due to various news and earnings reports.
Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of progression to overt heart failure. The study's primary endpoint was stabilization or i...
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P 500 also rose, gaining, 0.12% to 4,694.09. Check This Out: Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace'  Lea...
